Jubilant Industries   Report issue

For profit Phase 2
Founded: Bhartiagram India (1978)
Status: Acquired by Jubilant Innovation Ltd. (1978)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (4)

Key: Jubilant Industries (0) Acquired (4)

2-hydroxyoleic acid (3 trials)

iobenguane sulfate i-131 (2 trials)

jbi-802 (1 trial)

temozolomide (temodar) (2 trials)

Drugs in Other Trials (2)

Key: Jubilant Industries (0) Acquired (2)

adapalene (differin) (1 trial)

benzoyl peroxide (clearasil) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 7
  • # of Trial APIs: 6